InvestorsHub Logo
Replies to #335 on Biotech Values

DewDiligence

11/13/03 8:54 PM

#336 RE: rwwine #335

rwwine: I see the latest Alcon news as neutral vis-à-vis GENR’s partnership dealings. Far more material for GENR will be the Macugen phase 2/3 data to be released sometime this weekend.